Use of Technology in Pregnancy, ATTD 2025 Conference Catch-Up

In this episode of ATTD 2025 Conference Catch-Up, we dive into Use of Technology in Pregnancy, featuring innovative discussions on the challenges of managing diabetes during pregnancy, the impact of hybrid closed-loop and insulin delivery systems on glycemic control, and the need for individualized care to optimize outcomes for both mothers and babies.

Join us as we summarize key takeaways from these thought-provoking presentations:

  • How Do You Know That Your Pregnant Woman with Diabetes is Well Controlled? – Prof. Yariv Yogev
  • Use of the Medtronic 780G Hybrid Closed-Loop System in Type 1 Diabetes Pregnancy – Prof. Katrien Benhalima
  • The Role of CamAPS FX in T1D Pregnancy – Prof. Helen Murphy
  • Real-World Experience of Hybrid Closed-Loop Use During Type 1 Diabetes Pregnancy: A Spanish Perspective – Dr. Rosa Corcoy

This episode is an essential listen for obstetricians, endocrinologists, diabetes specialists, and healthcare professionals involved in managing pregnant women with diabetes. Learn about the latest advances in diabetes technology and how to apply them for optimal outcomes during pregnancy.

Enjoy the listen!

This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  

ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com 

Om Podcasten

ATTD is the ultimate forum for the latest in diabetes research, technology, and clinical innovation. This podcast channel offers two types of content designed for busy healthcare professionals: * ATTD Conference Catch-up: Short, AI-generated episodes with key insights from expert presentations & research discussions at the ATTD Conference. * Curated Series: In-depth, human-led conversations such as our current CGM in Focus series, supported by Dexcom, and previously Long-Acting Insulin Uncovered supported by Eli Lily. Whether you're a specialist, researcher, or industry leader, hit subscribe.